SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2394bortezomib and capecitabine in MBC Abstract No: 755 Author(s): K. Possinger, W.Ian@SI-5/13/2005
2393Bortezomib in Urothelial Cancer Abstract No: 4677 Author(s): S. S. Sridhar, W. Ian@SI-5/13/2005
2392Next 5 or 6 posts from me will contain 11 ASCO Velcade abstracts. If you're Ian@SI-5/13/2005
2391Velcade plus MDX-060. Yet another combination. Message 21312997Icebrg-5/11/2005
2390Millennium Pharmaceuticals Announces Webcast of American Society of Clinical OncIan@SI-5/9/2005
2389Looks like another thing for which we can thank Sarbanes-OxleyIan@SI-5/7/2005
2388Item 1.01 Entry into a Material DefiIcebrg-5/7/2005
2387Yet another "let's combine almost anything with Velcade and see if it htuck-5/6/2005
2386LAFAYETTE, Colo., May 5 /PRNewswire/ -- Dharmacon, Inc., the world’s leading supIcebrg-5/5/2005
2385[PI & pharmacologic data for Velcade] >>Clin Cancer Res. 2005 May 1;1tuck-5/4/2005
2384[MOA of Velcade's cytotoxic activity] >>Cancer Res. 2005 May 1;65(9):tuck-5/4/2005
2383Thanks, as always, Sales! >>I data - - TTT and AHA << AHA I know, tuck-4/28/2005
23824/28/05 1st q cc notes 1. 1st q review 11% decrease in r&d expenses bassoftware salesperson-4/28/2005
2381Millennium Pharma's Drive For Long-Term Growth 04.28.05, 12:52 PM ET CreditIcebrg-4/28/2005
2380Dr. Julian Adams' work at Infinity Infinity Presents Promising AnticanceracMike K-4/27/2005
2379Since I have IgD MM, this abstract is of particular importance. About 2 1/2 yeaMike K-4/27/2005
2378Combination of bortezomib, thalidomide, and dexamethasone in the treatment of reIcebrg-4/27/2005
2377Company-sponsored trial in patients with either brochioloalveolar carcinoma (BACtom pope-4/25/2005
2376UPDATE 1-Novartis, Millennium lose bid to extend patents Thu Apr 21, 2005 06:41 bob zagorin-4/21/2005
2375Q1 Earnings Preview: by: mr_nose_hair 04/18/05 09:48 pm Msg: 60400 of 60400 [CIcebrg-4/19/2005
2374Found this interesting: (from trisenox phase 2) <In addition, seven out of 10Extra Pale-4/15/2005
2373Cool. Current PII in MM is monotherapy.nigel bates-4/14/2005
2372there was an analyst on cnbc (sorry i missed them name as the tv was on in backgbob zagorin-4/14/2005
2371[Doxorubicin, Seliciclib, & Velcade versus MM] >>Blood. 2005 Apr 12; tuck-4/14/2005
2370Studies of VELCADE(R) (bortezomib) for Injection Show Emerging Role as CornerstoIcebrg-4/13/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News